Asha NJ, Tompkins D, Wilcox MH. Comparative analysis of prevalence,
risk factors, and molecular epidemiology of antibiotic-associated diarrhea due
to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus.J Clin Microbiol
. 2006;44:2785
-2791.
3.
Yokohama S, Aoshima M, Asama T, Shindo J, Maruyama J. Clostridium
difficile-associated enteric disease after percutaneous endoscopic
gastrostomy. J Gastroenterol.2009
;44:121
-125.
4.
Bliss DZ, Johnson S, Savik K, Clabots CR, Willard K, Gerding DN.
Acquisition of Clostridium difficile and Clostridium difficile-associated
diarrhea in hospitalized patients receiving tube feeding. Ann Intern
Med. 1998;129:1012
-1019.
5.
Sobotka L, Bratova M, Slemrova M, Manak J, Vizd'a J, Zadak Z.
Inulin as the soluble fiber in liquid enteral nutrition.Nutrition
. 1997;13:21
-25.
6.
Lewis S, Burmeister S, Brazier J. Effect of the prebiotic
oligofructose on relapse of Clostridium difficile-associated diarrhea: a
randomized, controlled study. Clin Gastroenterol Hepatol.2005
;3:442
-448.
7.
Edes TE, Walk BE, Austin JL. Diarrhea in tube-fed patients: feeding
formula not necessarily the cause. Am J Med.1990
;88:91
-93.
8.
Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of
irritable bowel syndrome: guidelines for effective dietary management.J Am Diet Assoc
. 2006;106:1631
-1639.
9.
Shepherd SJ, Parker SC, Muir JG, Gibson PR. Randomised,
placebo-controlled evidence of dietary triggers for abdominal symptoms in
patients with irritable bowel syndrome. Clin Gastroenterol
Hepatol. 2008;6:765
-771.
10.
Gearry RB, Irving PM, Nathan DM, et al, Shepherd SJ. PRG. The
effect of reduction of poorly absorbed, highly fermentable short-chain
carbohydrates (FODMAPs) on the symptoms of patients with inflammatory bowel
disease (IBD). Gut.2007
;56:A151
.
11.
Croagh C, Shepherd SJ, Berryman M, Muir JG, Gibson PR. Pilot study
on the effect of reducing dietary FODMAP intake on bowel function in patients
without a colon. Inflamm Bowel Dis.2007
;13:1522
-1528.
